Edition:
United Kingdom

Edge Therapeutics Inc (EDGE.OQ)

EDGE.OQ on NASDAQ Stock Exchange Global Select Market

0.41USD
21 Feb 2019
Change (% chg)

-- (--)
Prev Close
$0.41
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
99,115
52-wk High
$17.76
52-wk Low
$0.28

Chart for

About

Edge Therapeutics, Inc. is a clinical-stage biotechnology company that discovers, develops and seeks to commercialize hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening critical care conditions. The Company's initial product candidates target rare, acute, life-threat... (more)
No analyst recommendations are available for .

Overall

Beta: --
Market Cap(Mil.): $340.91
Shares Outstanding(Mil.): 30.85
Dividend: --
Yield (%): --

Financials

  EDGE.OQ Industry Sector
P/E (TTM): -- 69.44 33.70
EPS (TTM): -1.57 -- --
ROI: -43.75 8.92 14.45
ROE: -48.11 10.08 15.96

Earnings vs. Estimates